Shuttle Pharmaceuticals must file a Form 8-K with the SEC, and its securities may not be sold in the United States without proper registration.
3 reports, 1 independent
Updated Aug 12
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Shuttle Pharmaceuticals must file a Form 8-K with the SEC, and its securities may not be sold in the United States without proper registration.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Shuttle Pharmaceuticals (United States)
company in Rockville, United States
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- An SEC filing is required under US regulations.
- Alterity Therapeutics Limited disclosed corporate transactions with the Securities and Exchange Commission on September 1, 2026.
- Check-Cap Ltd. filed a registration statement with the SEC and obtained a prospectus from its Minneapolis office.
- The SEC declared a registration statement effective for a company, which trades securities on the NASDAQ Global Market.
- Veradermics, Incorporated disclosed company filings with the Securities and Exchange Commission on August 18, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- Unknown outlet